Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Martha Gulati: Oral MHT Is Associated With Increased Thrombotic Risk
Oct 1, 2026, 23:45

Martha Gulati: Oral MHT Is Associated With Increased Thrombotic Risk

Martha Gulati, Director of the Davis Women Heart Center at Houston Methodist DeBakey Heart and Vascular Center, shared The BMJ‘s post on X:

“Consistent with prior research, oral MHT is associated with increased thrombotic risk.

The same is not seen with transdermal MHT.”

The BMJ (British Medical Journal) shared a post on X about a recent article by Julie Berggreen et al., adding:

“Compared with no use of hormone therapy, oral menopausal hormone therapy was associated with increased venous thromboembolic risk regardless of dosage and treatment duration, finds study.

No increased thrombotic risks were observed with transdermal therapy.”

Title: Contemporary menopausal hormone therapy and thrombotic disease: nationwide nested case-control study

Authors: Julie Berggreen, Nelsan Pourhadi, Hannah Wood-Kurland, Ellen Løkkegaard, Christian Torp-Pedersen, Amani Meaidi

Martha Gulati

Stay updated on all scientific advances with Hemostasis Today.